Cargando…

Biochemical recurrence risk factors in surgically treated high and very high-risk prostate tumors

INTRODUCTION: High and very high-risk prostate cancers are tumors that display great variation in their progression, making their behaviour and consequent prognosis difficult to predict. We analyse preoperative and postoperative risk factors that could influence biochemical recurrence of these tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguilera, Alfredo, Bañuelos, Beatriz, Díez, Jesús, Alonso-Dorrego, Jose María, Cisneros, Jesus, Peña, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Urological Association 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643694/ https://www.ncbi.nlm.nih.gov/pubmed/26568870 http://dx.doi.org/10.5173/ceju.2015.485

Ejemplares similares

Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer
por: Yang, Cheng-Kuang, et al.
Publicado: (2023)

A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients
por: Wu, Xiangkun, et al.
Publicado: (2020)

Very high risk localized prostate cancer: definition and outcomes
por: Sundi, Debasish, et al.
Publicado: (2013)

Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer
por: Beauval, Jean-Baptiste, et al.
Publicado: (2016)

Preoperative Predictors of Biochemical Recurrence-Free Survival in High-Risk Prostate Cancer Following Radical Prostatectomy
por: Nkengurutse, Gerard, et al.
Publicado: (2020)

Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer
por: Park, Sung-Woo, et al.
Publicado: (2020)

The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer
por: Helfand, Brian T., et al.
Publicado: (2022)

Very high-risk prostate cancer: multimodality treatment will be the new frontier
por: Campobasso, Davide, et al.
Publicado: (2017)

Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors
por: Yamazaki, Hideya, et al.
Publicado: (2021)

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
por: Xiang, Yu-zhu, et al.
Publicado: (2013)

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
por: Xiang, Michael, et al.
Publicado: (2021)

High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression
por: Jonsson, Liv, et al.
Publicado: (2011)

Predicting biochemical recurrence in patients with high-risk prostate cancer using the apparent diffusion coefficient of magnetic resonance imaging
por: Yoon, Min Young, et al.
Publicado: (2017)

Pathological outcomes and biochemical recurrence-free survival after radical prostatectomy for high-risk prostate cancer in the Indian population
por: Bijalwan, Priyank, et al.
Publicado: (2018)

External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer
por: Bourbonne, Vincent, et al.
Publicado: (2020)

Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
por: Saad, Akram, et al.
Publicado: (2017)

Very-high-risk (VHR) localized prostate cancer: an indication for multimodal therapy
por: Sundi, Debasish, et al.
Publicado: (2019)

Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes
por: Abáigar, María, et al.
Publicado: (2016)

Impact of positive surgical margin on biochemical recurrence in localized prostate cancer
por: Lee, Wonchul, et al.
Publicado: (2021)

Oncological and functional outcomes of high-risk and very high-risk prostate cancer patients after robot-assisted radical prostatectomy
por: Chen, Wei-Hsin, et al.
Publicado: (2023)

Evaluation of biochemical recurrence in patients with high-risk prostate cancer treated with radical prostatectomy and radiotherapy plus androgen deprivation therapy
por: Yamamoto, Yutaka, et al.
Publicado: (2016)

Traumatic rupture of the corpus cavernosum: surgical management and clinical outcomes. A 30 years review
por: Rivas, Juan Gómez, et al.
Publicado: (2014)

High-Risk Prostate Cancer: A Very Challenging Disease in the Field of Uro-Oncology
por: Napodano, Giorgio, et al.
Publicado: (2021)

High surgeon volume and positive surgical margins can predict the risk of biochemical recurrence after robot-assisted radical prostatectomy
por: Porcaro, Antonio Benito, et al.
Publicado: (2019)

Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer
por: Jin, Kun, et al.
Publicado: (2019)

Feasibility of robot-assisted radical prostatectomy for very-high risk prostate cancer: surgical and oncological outcomes in men aged ≥70 years
por: Koo, Kyo Chul, et al.
Publicado: (2014)

The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients
por: Alvarez-Cubero, Maria Jesus, et al.
Publicado: (2013)

Image-guided, whole-pelvic, intensity-modulated radiotherapy for biochemical recurrence following radical prostatectomy in high-risk prostate cancer patients
por: Byun, Sang Jun, et al.
Publicado: (2018)

Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy
por: Utsumi, Takanobu, et al.
Publicado: (2023)

Laparoscopic radical cystectomy with prostate capsule sparing. Initial experience
por: Rivas, Juan Gómez, et al.
Publicado: (2016)

SURGICAL TREATMENT OF HIGH-RISK PROSTATIC CARCINOMA AND OLIGOMETASTATIC DISEASE
por: Mokos, Ivica, et al.
Publicado: (2019)

Management of Recurrent Paravalvular Leakage in a Very High-Risk Patient: A Case Report
por: Park, Sung Jun, et al.
Publicado: (2015)

Prostate Region-Wise Imaging Biomarker Profiles for Risk Stratification and Biochemical Recurrence Prediction
por: Sánchez Iglesias, Ángel, et al.
Publicado: (2023)

Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer
por: Kang, Ho Won, et al.
Publicado: (2016)

High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer
por: Eckhardt, Carolin, et al.
Publicado: (2021)

High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence
por: Nordby, Yngve, et al.
Publicado: (2017)

Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

In search of the ideal risk-scoring system for very high-risk cardiac surgical patients: a two-stage approach
por: Ranucci, Marco, et al.
Publicado: (2016)

Multi-scale tissue architecture analysis of favorable-risk prostate cancer: Correlation with biochemical recurrence
por: Pukl, Miha, et al.
Publicado: (2020)

Diagnostic and Therapeutic Challenges in a Patient with Synchronous Very High-Risk Prostate Adenocarcinoma and Anal Carcinoma
por: Wallach, Jonathan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2uu9hfmo1o9kc7pbb5cjvgii7s